content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001899935</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001551986</issuerCik>
        <issuerName>9 Meters Biopharma, Inc</issuerName>
        <secFileNumber>001-37797</secFileNumber>
        <issuerAddress>
          <com:street1>4509 Creedmoor</com:street1>
          <com:street2>Suite 201</com:street2>
          <com:city>Raleigh</com:city>
          <com:stateOrCountry>NC</com:stateOrCountry>
          <com:zipCode>27612</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>9192751933</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bethany L. Sensenig</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>UBS Financial Services Inc</name>
          <address>
            <com:street1>1000 Harbor Blvd</com:street1>
            <com:street2>3rd Floor</com:street2>
            <com:city>Weehawken</com:city>
            <com:stateOrCountry>NJ</com:stateOrCountry>
            <com:zipCode>07086</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>9500</noOfUnitsSold>
        <aggregateMarketValue>12000</aggregateMarketValue>
        <noOfUnitsOutstanding>14336356</noOfUnitsOutstanding>
        <approxSaleDate>04/21/2023</approxSaleDate>
        <securitiesExchangeName>nsdq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>04/21/2023</acquiredDate>
        <natureOfAcquisitionTransaction>RSU Vesting</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>9 Meters Biopharma</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>25089</amountOfSecuritiesAcquired>
        <paymentDate>04/21/2023</paymentDate>
        <natureOfPayment>Wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>Shares sold to cover tax withholding for restricted unit vest.</remarks>
      <noticeSignature>
        <noticeDate>04/21/2023</noticeDate>
        <signature>/s/ UBS Financial Services Inc, as attorney-in-fact for Bethany L. Sensenig</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2936}]
text: 144
  0001899935
  XXXXXXXX
  LIVE
  0001551986
  9 Meters Biopharma, Inc
  001-37797
  4509 Creedmoor
  Suite 201
  Raleigh
  NC
  27612
  9192751933
  Bethany L. Sensenig
  Officer
  Common
  UBS Financial Services Inc
  1000 Harbor Blvd
  3rd Floor
  Weehawken
  NJ
  07086
  9500
  12000
  14336356
  04/21/2023
  nsdq
  common
  04/21/2023
  RSU Vesting
  9 Meters Biopharma
  N
  25089
  04/21/2023
  Wire
  Y
  Shares sold to cover tax withholding for restricted unit vest.
  04/21/2023
  /s/ UBS Financial Services Inc, as attorney-in-fact for Bethany L. Sensenig